viimane versioon :
19/11/2024
uurimisrühmad - Institut Gustave Roussy, Department of Pharmacy    pdf  
Prantsusmaa
haigla
Institut Gustave Roussy, Department of Pharmacy
Villejuif
Viited   Viited   (8)  
1
Design and stability of pediatric oral formulation of imatinib
Hinterlang M, Gendron A, Fleury F, Rieutord A, Vrana A , Schlatter J, Annereau M. (maxime.annereau@gustaveroussy.fr)
J Oncol Pharm Practice - 2022 - ;
2
Microbiological and Physico-Chemical Stability of Ketamine Solution for Patient-Controlled Analgesia Systems.
Foy G, Poinsignon V, Mercier L, Laurent S, Paci A. (angelo.paci@gustaveroussy.fr)
RRJHCP - 2016 - ; 1, 3: 31-37.
3
Stability of Melphalan in 0,9% Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection.
Desmaris R.P, Mercier L, Paci A. (romain.desmaris@gustaveroussy.fr)
Drugs R D - 2015 - ;15:253-259.
4
Stability of Etoposide Solutions in Disposable Infusion Devices for Day Hospital Cancer Practices.
Klasen K, Kessari R, Mercier L, Valade C, Grill J, Desmaris R, Paci A. (angelo.paci@igr.fr)
Drugs R D - 2014 - ; 14:13?23.
5
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin.
Baker D S, Waldrop Bruce, Arnold John. ()
Int J Pharm Compound - 2010 - ; 14, 4: 346-349.
6
Microbiological and Physicochemical Stability of Oxycodone Hydrochloride Solutions for Patient-Controlled Delivery Systems.
Amri A, Achour AB, Chachaty E, Mercier L, Bourget P, Paci A. (angelo.paci@igr.fr)
J Pain Symptom Manage - 2010 - ; 40, 1: 87-94.
7
Microbiological and physicochemical stability of fentanyl and sufentanil solutions for patient-controlled delivery-systems.
Chapalain-Pargade S, Laville I, Paci A, Chachaty E, Mercier L, Bourget Ph. (angelo.paci@igr.fr)
J Pain Symptom Manage - 2006 - ; 32, 1: 90-97.
8
Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
Bouligand J, Storme T, Laville I, Mercier L, Oberlin O, Vassal J, Bourget Ph, Paci A. (angelo.paci@igr.fr)
J Pharm Biomed Anal - 2005 - ; 38: 180-185.

ingredientide nimekiri   molekulid uuritud   (11)  
antibiootikum Süsteravim Cefotaxime sodium
vähiravimite kapsel Cyclophosphamide
vähiravimite Süsteravim Etoposide
analgeetikum Süsteravim Fentanyl citrate
antikoagulant Süsteravim Heparin sodium
vähiravimite suukaudne lahus Imatinib
üldanesteetikum Süsteravim Ketamine hydrochloride
vähiravimite Süsteravim Melphalan
analgeetikum Süsteravim Oxycodone hydrochloride
analgeetikum Süsteravim Sufentanil citrate
antibiootikum Süsteravim Vancomycin hydrochloride

  Mentions Légales